药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Ritodrine
Coumaphos
The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Paliperidone.
Ritodrine
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Paliperidone.
Ritodrine
Lacidipine
The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Paliperidone.
Ritodrine
Efonidipine
The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Paliperidone.
Ritodrine
Aranidipine
The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Paliperidone.
Ritodrine
Pinaverium
The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Paliperidone.
Ritodrine
Trimebutine
The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Paliperidone.
Ritodrine
Vilanterol
The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Paliperidone.
Ritodrine
Olodaterol
The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Paliperidone.
Ritodrine
Flumequine
The risk or severity of QTc prolongation can be increased when Flumequine is combined with Paliperidone.
Ritodrine
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Paliperidone.
Ritodrine
Eribulin
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Paliperidone.
Ritodrine
Bupranolol
The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Paliperidone.
Ritodrine
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Paliperidone.
Ritodrine
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Paliperidone.
Ritodrine
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Paliperidone.
Ritodrine
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Paliperidone.
Ritodrine
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Paliperidone.
Ritodrine
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Paliperidone.
Ritodrine
Pasireotide
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Paliperidone.